Equity | 7. a. Authorized ● Unlimited number of common shares without par value. ● Unlimited number of first preferred shares without par value. ● Unlimited number of second preferred shares without par value. On January 27, 2021, the Corporation completed a one issued outstanding b. Share based compensation Share based compensation was recognized in the unaudited condensed consolidated statements of operations for the three month periods ended March 31, 2022 and 2021 as follows: Three month period ended March 31, 2022 2021 Exploration $ 235,683 $ 1,198,692 Consulting — 4,040 Corporate salaries and benefits 174,385 426,575 Directors’ fees 266,181 304,212 Total $ 676,249 $ 1,933,519 Share purchase options A summary of share purchase option activity within the Company’s share-based compensation plan (the “Plan”) for the year ended December 31, 2021 and three month period ended March 31, 2022 is as follows: Weighted Average Number of Options Exercise Price (C$) Balance December 31, 2020 1,959,588 $ 7.40 Options granted 1,013,500 11.40 Options expired (240,550) 9.17 Options terminated via SAR (109,850) 6.00 Options exercised (125,538) 4.99 Balance, December 31, 2021 2,497,150 $ 9.15 Options cancelled or forfeited (150,500) 9.03 Options expired (278,000) 8.86 Balance, March 31, 2022 2,068,650 $ 9.20 During the three month periods ended March 31, 2022 and 2021, the Company’s total share based compensation from options was $252,900 and $1,933,519, respectively. No options were granted during the three month period ended March 31, 2022. The grant date fair value of options granted during the three month period ended March 31, 2021 was approximately $4.9 million. The fair value of options granted is estimated at the time of the grant using the Black-Scholes option pricing model. The Company uses the Black-Scholes option valuation model. The risk-free interest rate is based on the government security rate with an equivalent term in effect as of the date of grant. The expected option lives and volatility assumptions are based on historical data of the Company. The weighted average inputs used in the Black-Scholes option pricing model for options granted during the three month period ended March 31, 2021 are: Three month period ended March 31, 2021 Fair value options granted $ 6.52 Risk-free interest rate 0.5% Expected term (in years) 5.0 Expected share price volatility 73% Expected dividend yield — An analysis of outstanding share purchase options as of March 31, 2022 is as follows: Options Outstanding Options Exercisable Range of Exercise Prices (C$) Number Price (C$) 1 Remaining Life 2 Number Price (C$) 1 Remaining Life 2 $3.50 - $5.90 213,150 5.22 1.49 176,900 5.44 1.18 $5.90 - $7.20 465,375 6.31 2.57 353,375 6.34 2.51 $7.21 - $9.70 599,625 9.42 2.15 429,625 9.55 1.79 $9.71 - $11.80 790,500 11.80 3.81 396,750 11.80 3.81 $3.50 - $11.80 2,068,650 9.20 2.81 1,356,650 8.84 2.49 1 2 As of March 31, 2022, all unvested options are expected to vest and unvested compensation of approximately $1.3 million will be recognized. The weighted average remaining period of vesting options is 1.2 years. As of March 31, 2022, the intrinsic value of outstanding and exercisable share purchase options is $71,259 and $42,927, respectively. During the three month periods ended March 31, 2022 and 2021, the intrinsic value of share purchase options exercised was nil and $432,153 respectively. Restricted Share Units The following table summarizes activity for restricted share units (“RSUs”) awarded under the Plan that vest over the required service period of the participant. Weighted Average Share Grant Date Units Fair Value Unvested, January 1, 2021 — $ — Granted 63,500 5.66 Distributed (vested) (21,166) 5.66 Unvested, December 31, 2021 42,334 5.66 Granted 330,098 4.03 Distributed (vested) (1,667) 4.03 Cancelled (1,255) 4.03 Unvested, March 31, 2022 369,510 4.22 During the three month period ended March 31, 2022, the Company awarded 330,098 RSUs that had a weighted average grant date fair value of $4.03 per RSU or approximately $1.3 million in total. During the three months ended March 31, 2022, the Company has recognized $110,740 in compensation expense related to RSUs and expects to record an additional $1.4 million in compensation expense over the next 1.9 years. There was no compensation expense for RSUs recorded during the three month period ended March 31, 2021. The unvested units at March 31, 2022 are scheduled to vest as follows: Remainder of 2022 21,166 2023 130,781 2024 109,615 2025 107,948 Total 369,510 Unvested units will be forfeited by participants upon termination of employment in advance of vesting, with the exception of termination due to retirement if certain criteria are met. Performance Share Units The following table summarizes activity for performance share units (“PSUs”) and market-based performance share units (“MPSUs”) awarded under the Plan: Weighted Average Share Grant Date Units Fair Value Unvested, January 1, 2021 — $ — Granted 10,750 5.66 Unvested, December 31, 2021 10,750 5.66 Granted 257,451 6.90 Cancelled (3,918) 5.80 Unvested, March 31, 2022 264,283 6.87 During the three months ended March 31, 2022, the Company has recognized $55,666 in compensation expense related to PSUs and MPSUs and expects to record an additional $1.75 million in compensation expense over the next 2.8 years. The PSUs and MPSUs are scheduled to vest as follows: 7,250 awards in September 2022, 7,500 awards in September 2023, and 249,533 in March 2025. There was no compensation expense for PSUs and MPSUs recorded during the three-month period ended March 31, 2021. PSUs Market-based PSUs During the three month period ended March 31, 2022, the Company awarded 249,533 MPSUs that had a weighted grant date fair value of $6.99 per MPSU or approximately $1.75 million in total. The grant date fair value of MPSUs was estimated using a Monte Carlo simulation model. Assumptions and estimates utilized in the model include expected volatilities of the Corporation’s stock and the GDXJ Index, the Company’s risk-free interest rate and expected dividends. The probabilities of the actual number of MPSUs expected to vest and resultant actual number of shares of common stock expected to be awarded are reflected in the grant date fair values of the various MPSU awards. The per MPSU grant date fair value of $6.99 for the market condition was based on the following variables: Three month period ended March 31, 2022 Risk-free interest rate 1.61% Expected term (in years) 3.0 Expected share price volatility 63.35% Expected dividend yield — The expected volatility utilized is based on the historical volatilities of the Corporation’s common stock and the GDXJ Index in order to model the stock price movements. The volatility used was calculated over the most recent three year period. The risk-free interest rates used are based on the implied yield available on a U.S. Treasury zero-coupon bill with a term equivalent to the Performance Period. The expected dividend yield of zero was used since it is the mathematical equivalent to reinvesting dividends in each issuing entity over the Performance Period. Deferred Share Units The following table summarizes activity for deferred share units (“DSUs”) awarded under the Plan: Weighted Average Share Grant Date Units Fair Value Outstanding, January 1, 2021 — $ — Granted 29,213 5.39 Outstanding, December 31, 2021 29,213 5.39 Granted 62,669 4.10 Outstanding, March 31, 2022 91,882 4.51 Under the Plan, the Company may issue DSUs to non-employee directors. During the three month period ended March 31 2022, 62,669 shares with a fair value of $256,943 were granted to the non-employee directors and the related compensation expense was charged to directors’ fees in the unaudited condensed consolidated statements of operations. There was no compensation expense for DSUs recorded during the three-month period ended March 31, 2021. c. Warrants There was a total of 200,000 warrants outstanding as of March 31, 2022. See Note 4. |